共有 50 笔近期内部人交易记录记录，涉及 Spruce Biosciences, Inc. (SPRB), 包括 20 笔买入 和 27 笔卖出. 内部人买入总额为 $677.67K 内部人卖出总额为 $8.74M.
近期活跃的重要内部人包括 Hooks Corwin Dale, Szwarcberg Javier B., Gharib Samir M.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — SPRB
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-09 |
Hooks Corwin Dale |
Officer |
未知 |
- |
- |
- |
- |
| 2026-03-09 |
Hooks Corwin Dale |
Chief Commercial Officer |
限制性股票授予 (RSU) |
11,000 |
- |
- |
11,000 |
| 2025-12-31 |
Szwarcberg Javier B. |
Chief Executive Officer |
限制性股票授予 (RSU) |
4,690 |
$4.53 |
$21.25K |
19,004 |
| 2025-12-15 |
Gharib Samir M. |
President and CFO |
期权行权（卖出） |
496 |
- |
- |
497 |
| 2025-12-15 |
Szwarcberg Javier B. |
Chief Executive Officer |
期权行权（卖出） |
1,480 |
- |
- |
1,480 |
| 2025-12-11 |
Ways Douglas Kirk |
Interim Chief Medical Officer |
股份退回 |
400 |
$169.50 |
$67.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
期权行权（卖出） |
1,900 |
- |
- |
5,700 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU 预扣税 |
2,194 |
$88.41 |
$193.97K |
12,998 |
| 2025-12-11 |
Spiegelman Daniel K |
Director |
股份退回 |
458 |
$564.00 |
$258.31K |
- |
| 2025-12-11 |
Grey Michael G |
Executive Chairman |
股份退回 |
387 |
$108.00 |
$41.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
股份退回 |
733 |
$1,506.00 |
$1.1M |
- |
| 2025-12-11 |
Simpson Camilla V |
Director |
股份退回 |
173 |
$108.00 |
$18.68K |
- |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
股份退回 |
10,000 |
$344.25 |
$3.44M |
- |
| 2025-12-11 |
Barretto-ko Percival |
Director |
股份退回 |
800 |
$169.50 |
$135.6K |
- |
| 2025-12-11 |
Walbert Keli |
Officer |
未知 |
- |
- |
- |
- |
| 2025-12-11 |
Walbert Keli |
Director |
限制性股票授予 (RSU) |
3,400 |
$88.41 |
$300.59K |
3,400 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
限制性股票授予 (RSU) |
1,666 |
$104.13 |
$173.48K |
1,666 |
| 2025-12-10 |
Gharib Samir M. |
President and CFO |
期权行权（卖出） |
514 |
- |
- |
1,539 |
| 2025-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
期权行权（卖出） |
1,196 |
- |
- |
3,588 |
| 2025-10-20 |
Gharib Samir M. |
President and CFO |
期权行权（卖出） |
2,053 |
- |
- |
- |
| 2025-10-20 |
Szwarcberg Javier B. |
Chief Executive Officer |
期权行权（卖出） |
4,784 |
- |
- |
- |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
未知 |
- |
- |
- |
1,051 |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
知情卖出 |
25 |
$17.46 |
$436.39 |
1,050 |
| 2025-07-23 |
Ways Kirk |
Interim Chief Medical Officer |
限制性股票授予 (RSU) |
30,000 |
$0.12 |
$3.71K |
30,000 |
| 2025-07-22 |
Spiegelman Daniel K |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Grey Michael G |
Executive Chairman |
限制性股票授予 (RSU) |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Aynechi Tiba |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Muralidhar Bali |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Simpson Camilla V |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Barretto-ko Percival |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2024-12-16 |
Gharib Samir M. |
President and CFO |
期权行权（卖出） |
37,250 |
- |
- |
74,500 |
| 2024-12-16 |
Szwarcberg Javier B. |
Chief Executive Officer |
期权行权（卖出） |
111,000 |
- |
- |
222,000 |
| 2024-12-16 |
Charlton Ralph William Iii |
Chief Medical Officer |
期权行权（卖出） |
31,750 |
- |
- |
63,500 |
| 2024-12-10 |
Gharib Samir M. |
President and CFO |
期权行权（卖出） |
154,000 |
- |
- |
154,000 |
| 2024-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU 预扣税 |
128,020 |
$0.54 |
$68.75K |
338,101 |
| 2024-12-10 |
Charlton Ralph William Iii |
Chief Medical Officer |
期权行权（卖出） |
106,400 |
- |
- |
106,400 |
| 2024-05-22 |
Spiegelman Daniel K |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Grey Michael G |
Executive Chairman |
限制性股票授予 (RSU) |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Aynechi Tiba |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Muralidhar Bali |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Simpson Camilla V |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Ways Kirk |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Barretto-ko Percival |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-03-21 |
Novo Holdings A/s |
10 Percent Owner |
知情卖出 |
465,021 |
$0.75 |
$350.95K |
2,550,000 |
| 2024-03-20 |
Novo Holdings A/s |
10 Percent Owner |
知情卖出 |
359,979 |
$0.73 |
$264.08K |
3,015,021 |
| 2024-03-19 |
Novo Holdings A/s |
10 Percent Owner |
知情卖出 |
593,000 |
$0.76 |
$447.72K |
3,375,000 |
| 2024-03-18 |
Novo Holdings A/s |
10 Percent Owner |
知情卖出 |
842,020 |
$0.77 |
$647.01K |
3,968,000 |
| 2024-03-14 |
Novo Holdings A/s |
10 Percent Owner |
知情卖出 |
1,912,316 |
$0.89 |
$1.7M |
4,810,020 |
| 2024-03-14 |
Gharib Samir M. |
President and CFO |
限制性股票授予 (RSU) |
154,000 |
- |
- |
154,000 |
| 2024-03-14 |
Szwarcberg Javier B. |
Chief Executive Officer |
限制性股票授予 (RSU) |
358,800 |
- |
- |
358,800 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
